Last $0.0001 USD
Change Today 0.00 / 0.00%
Volume 0.0
GNYS On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/17/14 All times are local (Market data is delayed by at least 15 minutes).

genosys inc (GNYS) Snapshot

Open
$0.0001
Previous Close
$0.0001
Day High
$0.0001
Day Low
$0.0001
52 Week High
09/12/13 - $0.02
52 Week Low
07/7/14 - $0.0001
Market Cap
8.6K
Average Volume 10 Days
650.0
EPS TTM
$-0.03
Shares Outstanding
86.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GENOSYS INC (GNYS)

Related News

No related news articles were found.

genosys inc (GNYS) Related Businessweek News

No Related Businessweek News Found

genosys inc (GNYS) Details

GeNOsys, Inc., a medical research and development company, specializes in pharmaceutical, bio-technical, and medical gas generating systems. Its systems generate medical grade nitric oxide, as well as various other medical gases for the treatment of human conditions and diseases. The company focuses on distributing its products through distributors. GeNOsys, Inc. is based in Provo, Utah.

4 Employees
Last Reported Date: 03/15/11

genosys inc (GNYS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

genosys inc (GNYS) Key Developments

SEC Orders Hearings On Registration Suspension Or Revocation Against GeNOsys For Failure To Make Required Periodic Filings

Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of GeNOsys, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.

Gordon Barker Resigns as Director of GeNOsys, Inc

On September 19, 2013, the board of directors of GeNOsys, Inc. accepted the resignation of Gordon Barker as a director. Mr. barker’s new responsibilities make him unavailable to make company decisions as a director in a timely manner.

GeNOsys, Inc. Announces the Resignation of Steve Quesenberry as Director

On August 23, 2013, the Board of Directors accepted the resignation of Steve Quesenberry as a director of GeNOsys, Inc. Mr. Quesenberry's new responsibilities preclude him from serving. There were no disagreements between Mr. Quesenberry and the Company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNYS:US $0.00 USD 0.00

GNYS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GNYS.
View Industry Companies
 

Industry Analysis

GNYS

Industry Average

Valuation GNYS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOSYS INC, please visit www.genosysusa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.